Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Ultragenyx
Biotech
Ultragenyx tweaks gene therapy dosing to dial up efficacy
A minority of patients have come off standard-of-care drugs, leading the biotech to enroll a new cohort on a tweaked regimen to dial up the efficacy.
Nick Paul Taylor
Oct 4, 2024 8:46am
Ultragenyx gets green light to seek FDA approval of gene therapy
Jun 13, 2024 5:55am
Ultragenyx, Mereo's brittle bone drug sustains fracture rate cut
Jun 12, 2024 8:55am
Ultragenyx's ph. 3 win for glycogen storage disease gene therapy
May 30, 2024 4:00pm
Ultragenyx, Mereo's bone disease med cuts fractures by 67%
Oct 16, 2023 12:39pm
FDA's Marks wants more quick approvals for rare disease drugs
Jul 28, 2023 11:36am